New Zealand markets close in 11 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
372.16-7.44 (-1.96%)
At close: 04:03PM EST
372.16 0.00 (0.00%)
After hours: 04:17PM EST
Currency in USD

Valuation measures4

Market cap (intra-day) 31.97B
Enterprise value 31.60B
Trailing P/E 53.48
Forward P/E 50.00
PEG ratio (5-yr expected) 3.30
Price/sales (ttm)12.23
Price/book (mrq)14.52
Enterprise value/revenue 11.79
Enterprise value/EBITDA 39.19

Trading information

Stock price history

Beta (5Y monthly) 0.97
52-week change 324.50%
S&P500 52-week change 321.05%
52-week high 3475.35
52-week low 3253.86
50-day moving average 3431.59
200-day moving average 3395.45

Share statistics

Avg vol (3-month) 3398.8k
Avg vol (10-day) 3460.31k
Shares outstanding 574.08M
Implied shares outstanding 6N/A
Float 873.59M
% held by insiders 10.63%
% held by institutions 193.18%
Shares short (30 Dec 2021) 4895.87k
Short ratio (30 Dec 2021) 42.4
Short % of float (30 Dec 2021) 41.37%
Short % of shares outstanding (30 Dec 2021) 41.21%
Shares short (prior month 29 Nov 2021) 41.12M

Dividends & splits

Forward annual dividend rate 40.72
Forward annual dividend yield 40.19%
Trailing annual dividend rate 30.68
Trailing annual dividend yield 30.18%
5-year average dividend yield 40.41
Payout ratio 48.43%
Dividend date 301 Feb 2022
Ex-dividend date 417 Jan 2022
Last split factor 22:1
Last split date 326 Sep 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)29 Sep 2021

Profitability

Profit margin 22.85%
Operating margin (ttm)25.80%

Management effectiveness

Return on assets (ttm)15.10%
Return on equity (ttm)31.24%

Income statement

Revenue (ttm)2.68B
Revenue per share (ttm)36.24
Quarterly revenue growth (yoy)28.90%
Gross profit (ttm)767.8M
EBITDA 808.1M
Net income avi to common (ttm)612.5M
Diluted EPS (ttm)8.06
Quarterly earnings growth (yoy)113.40%

Balance sheet

Total cash (mrq)688M
Total cash per share (mrq)9.29
Total debt (mrq)315.6M
Total debt/equity (mrq)14.33
Current ratio (mrq)2.86
Book value per share (mrq)29.72

Cash flow statement

Operating cash flow (ttm)571.9M
Levered free cash flow (ttm)226.4M